Search is Powered by Google
Breast Cancer News

AACR Seeks Submissions For 2008 Susan G. Komen For The Cure - AACR Outstanding Investigator Award For Breast Cancer Research

Main Category: Breast Cancer
Also Included In: Cancer / Oncology
Article Date: 25 Jun 2008 - 4:00 PST

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

The American Association for Cancer Research (AACR), in partnership with Susan G. Komen for the Cure, is currently accepting nominations for the 2008 Susan G. Komen for the Cure- AACR Outstanding Investigator Award for Breast Cancer Research.

A result of the new partnership between AACR and the Cancer Therapy and Research Center (CTRC) at the University of Texas Health Science Center to jointly present the CTRC-AACR San Antonio Breast Cancer Symposium in 2008, the Outstanding Investigator Award for Breast Cancer Research will recognize an investigator whose novel and significant work has had, or may have, a far-reaching impact on the etiology, detection, diagnosis, treatment or prevention of breast cancer.

Advances in breast cancer research potentially arise from all scientific disciplines and AACR hopes to receive nominations from a variety of research areas.

Nominations are open to all basic, translational and clinical cancer researchers and individual investigators who are affiliated with any institution involved in basic cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world. The award honors investigators relatively early in their careers, therefore, nominees must be no more than 50 years old at the time the award is received. The award winner will deliver a 30-minute lecture about his or her research at the 2008 CTRC-AACR San Antonio Breast Cancer Symposium, December 10-14, 2008.

Through the new partnership between AACR and CTRC, Susan G. Komen for the Cure will help support significant accomplishments in breast cancer research, enhance the education and training of young scientists, provide a bridge for collaboration and interaction between basic scientists and clinicians, and introduce an outstanding corps of investigators to breast cancer research.

Along with the Outstanding Investigator Award, Susan G. Komen for the Cure will support three additional new initiatives in conjunction with the CTRC-AACR San Antonio Breast Cancer Symposium. In an effort to educate basic scientists and clinicians about the latest advances in each other's fields, Susan G. Komen for the Cure will sponsor the CTRC-AACR San Antonio Breast Cancer Symposium Educational Sessions, addressing emerging targets, signal transduction pathways controlling cell proliferation and cell death in breast cancer, clinical trials and pathobiology.

Additional support from Komen will fund the Susan G. Komen for the Cure-AACR Scholar-in-Training Awards and Minority Scholar Awards for Breast Cancer Research. These awards aim to expand the pool of researchers contributing new and innovative ideas to breast cancer research.

For more information on eligibility criteria, the nomination process and other details about the Susan G. Komen for the Cure - AACR Outstanding Investigator Award for Breast Cancer Research, please click here, . Submissions for this award should be sent to awards@aacr.org. Inquiries from investigators regarding this award should be directed to monique.eversley@aacr.org. The nomination deadline is Thursday July, 10, 2008

The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, AACR is the world's oldest and largest professional organization dedicated to advancing cancer research. The membership includes 28,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and 80 other countries. AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants. The AACR Annual Meeting attracts more than 17,000 participants who share the latest discoveries and developments in the field. Special Conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment, and patient care. AACR publishes five major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Epidemiology, Biomarkers & Prevention. Its most recent publication and its sixth major journal, Cancer Prevention Research, is dedicated exclusively to cancer prevention, from preclinical research to clinical trials. The AACR also publishes CR, a magazine for cancer survivors, patient advocates, their families, physicians, and scientists. CR provides a forum for sharing essential, evidence-based information and perspectives on progress in cancer research, survivorship, and advocacy.

American Association for Cancer Research


Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Understanding And Treating Triple-Negative Breast Cancer
07 Jan 2009
Triple-negative breast cancer is a subtype of breast cancer that is clinically negative for expression of estrogen and progesterone receptors (ER/PR) and HER2 protein. It is characterized by its unique molecular profile...


Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

Breast Cancer Treatment: Get Involved image Breast Cancer Treatment: Get Involved

Today, breast cancer patients may be treated by a multidisciplinary team of specialists, consisting of nurses, oncologists, surgeons, social workers, nutritionists and genetic counselors. However, patients, too, have a critical role in their treatment...

View more videos...